Bristol-Myers Squibb (NYSE: BMY) has long been a rumored takeover target, but news earlier in the week that Peter Dolan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE